Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
Swiss Novartis is entering a licensing agreement with a Chinese biotech worth as much as $7.8 billion. It comes after several pharma peers announced deals with China-based drug developers over the past two weeks. ING estimates that China will…
Why Eric Cantor Going To Head Big Pharma Is Super Swampy
That cynical reaction perfectly summed up the recent news that former House Majority Leader Eric Cantor, R-Va., will become the next head of the Pharmaceutical Research and Manufacturers of America (PhRMA) in November. If not exactly a match made…
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?
Whether it's biotech stocks or regular pharmaceutical stocks, when investors buy a particular name in healthcare, they are making a wager on a single company's pipeline. However, there is one unique name within this space that enables investors to…
Orimed Pharma launches PrBALANSYA, Canada's only escitalopram oral solution
Orimed Pharma, part of the JAMP Pharma Group, launches BALANSYA, the only escitalopram oral solution available in Canada. The 2 mg/mL formulation gives healthcare professionals an oral liquid option when prescribing escitalopram. Following the…
FDA cancels drug sale licence of Cipla facility in Pune
The Maharashtra Food and Drug Administration (FDA) on Friday said it has cancelled the drug sale and distribution licences of Cipla Pharma & Life Sciences Ltd's carrying and forwarding (C&F) warehouse at Wadki in Pune following detection of alleged…
Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.
If you've been looking for high-yield stocks, Pfizer (PFE -1.40%) may have crossed your radar screen. As shares of the pharma giant slipped over the past few years, its dividend yield marched higher, and in recent times, settled at 6%. High…
Aurobindo arm Acrotech Biopharma forays into U.S. dermatology market with atopic dermatitis ointment
Aurobindo Pharma subsidiary Acrotech Biopharma has launched Adquey (difamilast 1%) ointment, a non-steroidal topical treatment for mild-to-moderate atopic dermatitis, in the U.S. The product will compete in a market estimated to be around $1.3…
American Healthcare REIT: A Dip Buy Driven By Senior-Care And Outpatient Tailwind (NYSE:AHR)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Prediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker
Eli Lilly (NYSE:LLY | LLY Price Prediction) trades at $1,184.92, which gives it a market value of about $1.057 trillion. The 24/7 Wall St. price target for Eli Lilly is $1,401.42 over the next 12 months. That means 18.27% upside and earns a…
Gavin Newsom Signs Bill Banning 'Robo Bosses' as Part of California Crackdown on AI
A day after President Donald Trump had lunch with some of the nation's top AI executives, California Gov. Gavin Newsom signed a slate of bills Wednesday aimed at putting new guardrails on the technology. Chief among them was the “ No Robo…
The Scottish Impact Awards - full list of winners revealed
Through regular wellbeing conversations, training for managers and by establishing a network of Mental Health First Aiders, he has banished stigma and created a supportive environment, dramatically reducing stress-related absences within the…
Regeneron Pharmaceuticals, Inc. (REGN) Discusses Expanded Collaboration on Next-Generation Long-Acting Immunology Antibodies Transcript
Regeneron Pharmaceuticals, Inc. (REGN) Discusses Expanded Collaboration on Next-Generation Long-Acting Immunology Antibodies October 1, 2026 8:00 AM EDT Ryan Crowe - Senior Vice President of Investor Relations & Strategic Analysis…
One of our most recent defensive buys cleared a hurdle and its stock jumped
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks were hanging in there on Thursday, with the S & P 500 down…
The Trump administration's shrinking Medicare drug price experiment
President Trump's signature threat to force drugmakers into offering Medicare the lowest prices in the world has ended in a whimper, with a regulation that's expected to impact just a handful of manufacturers. Yes, but: The legal ramifications of…
Ionna's CEO Says Charging Has to Pay or EVs Die
The pitch for a nationwide charging network has always been dressed up as a public good. The top executive at EV charging startup Ionna would like to remind everyone it's a business that needs to make money, or none of this works. Seth Cutler, who…
Receive a Daily briefing on Pharma Industry News
Get Started